Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cellab is an Andorra-based biotechnology company and advanced laboratory specializing in the cryopreservation and therapeutic application of stem cells. Founded in 2008, the company operates one of the most technologically advanced stem cell banks in Europe, offering services for the collection and storage of cells from umbilical cord blood, tissue, dental pulp, and adipose tissue. Beyond biobanking, Cellab is actively involved in regenerative medicine R&D, focusing on the development of Mesenchymal Stem Cell (MSC) treatments for orthopedic and aesthetic conditions. The company collaborates with leading clinical institutions, such as the Teknon Medical Center, to advance stem cell-based therapies for osteoarthritis and sports-related recovery. It operates state-of-the-art facilities compliant with international quality standards to support its clinical research and therapeutic offerings.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cellab.